Inhaled carbon monoxide increases vasodilation in the microvascular circulation
-
Add time:07/30/2019 Source:sciencedirect.com
Preeclampsia (PE) is characterized by systemic maternal endothelial dysfunction. Changes in endothelial reactivity have been reported before the onset of clinical signs of PE, and continuing into the post-partum period. Women who smoke during pregnancy have a 33% reduced risk of developing PE. This reduced risk is hypothesized to be, in part, attributed to carbon monoxide (CO), a by-product of cigarette combustion and a known endogenous vasodilator. Determining the vascular effects of CO in healthy women, may inform how CO can improve endothelial function and have promise as a novel therapeutic for PE. As part of a pilot study to determine the vascular effects of CO, the aim of this study was to measure microvascular vasodilation following low-dose CO inhalation. Non-pregnant women inhaled ambient room air or 250 ppm CO for 24 min during microvascular assessment using laser speckle contrast imaging. Changes in vascular flux were measured in the forearm before, during, and following a three-minute arterial occlusion. CO inhalation increased end-tidal breath CO (EtCO) (9.1 ± 1.9 vs. 1.8 ± 0.7 ppm, p < 0.05) and increased microvascular vasodilation, measured as difference of maximum level/resting level ratio (mean difference 0.476, 95% confidence interval (CI) = 0.149–0.802 vs. 0.118, 95% CI = −0.425–0.662, p < 0.05). Women who inhaled CO had a longer time to half recovery of endothelial function following arterial occlusion, compared to controls (hazard ratio 0.29, 95% CI = 0.10–0.91, p = 0.033). Inhalation of CO moderately increased EtCO and resulted in an increased microvascular response, suggesting that CO may have potential as a therapeutic for PE.
We also recommend Trading Suppliers and Manufacturers of Potassium monoxide (cas 12136-45-7). Pls Click Website Link as below: cas 12136-45-7 suppliers
Prev:Direct Conversion of CO2 into Methanol over Promoted Indium oxide (cas 12136-26-4)-based Catalysts
Next:Carbon monoxide hydrogenation on potassium promoted Mo2N catalysts) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Potassium promotion effects in carbon nanotube supported molybdenum sulfide catalysts for carbon monoxide hydrogenation08/07/2019
- Outcome and prognostic factors of patients treated in the intensive care unit for carbon monoxide poisoning08/06/2019
- Serum lactate as a predictor of neurologic outcome in ED patients with acute carbon monoxide poisoning08/05/2019
- Potassium channels contribute to the increased sensitivity of the rabbit carotid artery to hydrogen sulfide in diabetes08/04/2019
- Towards carbon monoxide sensors based on europium doped cerium dioxide08/03/2019
- Impact of potassium content on the structure of molybdenum nanophases in alumina supported catalysts and their performance in carbon monoxide hydrogenation08/02/2019
- Gaseous and particulate emissions from a chimneyless biomass cookstove equipped with a potassium catalyst08/01/2019
- Carbon monoxide hydrogenation on potassium promoted Mo2N catalysts07/31/2019
-
Health and Chemical more >
-
Related Products
- Potassium (2S,3S)-3-(ethoxycarbonyl)oxirane-2-carboxylate
- Potassium (4-formylphenyl)trifluoroborate
- Potassium (bromomethyl)trifluoroborate
- Potassium (R)-((3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino)(4-hydroxyphenyl)acetate
- Potassium (R)-(4-hydroxyphenyl)((3-methoxy-1-methyl-3-oxoprop-1-enyl)amino)acetate
- Potassium (R)-[(3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino]phenylacetate
- Potassium [(cyanomethyl)thio]acetate
- Potassium 1,2,3,6-tetrahydro-5-nitro-2,6-dioxopyrimidine-4-carboxylate
- Potassium 2,2-dimethyl-1,3-dioxolane-4-carboxylate
- Potassium 2,3,3-trimethyl-3H-indole-5-sulfonate


